A Potential Role for Alterations of Zinc and Zinc Transport Proteins in the Progression of Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
Abstract
Although multiple studies have suggested a role for alterations of zinc (Zn) and zinc transport (ZnT) proteins in the pathogenesis of Alzheimer's disease, the exact role of this essential trace element in the progression of the disease remains unclear. The following review discusses the normal role of Zn and ZnT proteins in brain and the potential effects of their alteration in the pathogenesis of Alzheimer's disease, particularly in the processing of the amyloid-beta protein precursor and amyloid-beta peptide generation and aggregation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Lovell (93) reported that AB/Zn ratios 1:0.1 and 1:0.01 result in a protective activity against AB toxicity.”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [93]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · cited 1×
“…[9,10], single nucleotide polymorphisms in the gene that codes for ubiquilin-1 [11], a genetic locus on chromosome 10 that includes the insulin-degrading enzyme [12–14] that may interact with and degrade A β , inherited variants in SORL1 [15], and the presence of apolipoprotein E4 alleles [16].”
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762 · cited 1×
“…etiologic/pathogenic mechanisms have been suggested for the cause of AD including genetic defects [10,30], the amyloid cascade hypothesis (reviewed in [31]), trace element toxicity (reviewed in [32]), the oxidative stress hypothesis [33], mitochondrial defects [34], or a combination of the above.”
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237 · cited 1×
“], hyperlipidemia [23], hypertension [24], heart disease [25], smoking [26,27], elevated plasma homo-cysteine [28], and obesity [29].”
The biochemical basis of zinc physiology
Vallee, B. L., & Falchuk, K. H. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.1.79 · Cited by 2,990 · cited 1×
“Zn is an essential trace element [35] that is redox-inert with structural,catalytic, and regulatory roles [36– 38].”
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577 · cited 1×
“…identified for AD include age [2], genet-ic factors including presenilin 1 (PS1) and 2 (PS2) and amyloid-β protein precursor (A β PP) mutations [9,10], single nucleotide polymorphisms in the gene that codes for ubiquilin-1 [11], a genetic locus on chromosome 10 that includes the…”
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 2×
“Without preventive strategies, there may be 14 million Americans with AD by the year 2040 [1].”
InfluentialCopper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Self-citationOxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · cited 3×
“Transport of Zn into the brain occurs via the blood/brain and blood/cerebrospinal fluid(CSF) barriers [56] where brain capillary endothelial cells respond to changes in Zn status by increasing or decreasing Zn uptake [57].”
The neurobiology of zinc in health and disease
Frederickson, C. J., Koh, J.-Y., & Bush, A. I. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1671 · Cited by 1,850 · cited 1×
“Regionally, Zn concentrations, particularly vesicular Zn, are highest in the hippocampus, amygdala, and neocortex and are relatively low in cerebellum [58,59], a pattern that mirrors the distribution of pathologic features in AD.”
Statins and the risk of dementia
Jick, H., Zornberg, G., Jick, S., Seshadri, S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,759
15-year longitudinal study of blood pressure and dementia
Skoog, I., Nilsson, L., Persson, G., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L.-A., Odén, A., & Svanborg, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90608-x · Cited by 1,726 · cited 1×
“], hyperlipidemia [23], hypertension [24], heart disease [25], smoking [26,27], elevated plasma homo-cysteine [28], and obesity [29].”
Purification and cloning of amyloid precursor protein β-secretase from human brain
Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., et al. (1999) · Nature · doi:10.1038/990114 · Cited by 1,612
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526 · cited 1×
“Additionally, several transgenic models of AD [82,126,148] including those with mutant APP, mutant APP/PS1 or mutant APP/PS1 and tau show increased Aβ deposition.”
Rapid induction of Alzheimer A beta amyloid formation by zinc
Bush, A., Pettingell, W., Multhaup, G., d Paradis, M., Vonsattel, J., Gusella, J., Beyreuther, K., Masters, C., & Tanzi, R. (1994) · Science · doi:10.1126/science.8073293 · Cited by 1,522 · cited 4×
“In addition to its effect on A β PP processing, several reports indicate that Zn at low physiological concentrations [69,178–180] induces A β aggregation, although later studies indicate that higher Zn concentrations are required [181,182] for significant aggregation (fibril formation).”
InfluentialCherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · cited 3×
“Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer’s disease brain: mechanisms and consequences.”
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417 · cited 1×
“Fibrillar A β , the predominant component of insoluble amyloid plaques, is neurotoxic [190, 191].”
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
The metallobiology of Alzheimer's disease
Bush, A. I. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00067-5 · Cited by 1,315 · cited 1×
“Based on the potential role of Zn and Cu in the deposition of A β in AD brain, there has been considerable interest in the use of metal chelators to decrease amyloid pathology [203].”
Mitochondrial Genetics: A Paradigm for Aging and Degenerative Diseases?
Wallace, D. C. (1992) · Science · doi:10.1126/science.1533953 · Cited by 1,262 · cited 1×
“…etiologic/pathogenic mechanisms have been suggested for the cause of AD including genetic defects [10,30], the amyloid cascade hypothesis (reviewed in [31]), trace element toxicity (reviewed in [32]), the oxidative stress hypothesis [33], mitochondrial defects [34], or a combination of the above.”
Koh, J. Y., & Choi, D. W. (1987) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(87)90041-0 · Cited by 1,260
Biochemistry of metallothionein
Kaegi, J. H. R., & Schaeffer, A. (1988) · Biochemistry · doi:10.1021/bi00423a001 · Cited by 1,225
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167
Translating cell biology into therapeutic advances in Alzheimer's disease
Selkoe, D. J. (1999) · Nature · doi:10.1038/399a023 · Cited by 1,166 · cited 1×
“Further processing by the γ -secretase complex at the plasma membrane (reviewed in [174]) leads to formation of A β , a 40 or 42 amino acid peptide that is the major component of SP in AD [175].”
The Genetic Defect Causing Familial Alzheimer's Disease Maps on Chromosome 21
St George-Hyslop, P. H., Tanzi, R. E., Polinsky, R. J., Haines, J. L., Nee, L., Watkins, P. C., Myers, R. H., Feldman, R. G., Pollen, D., Drachman, D., et al. (1987) · Science · doi:10.1126/science.2880399 · Cited by 1,163
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M., & Teplow, D. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22364 · Cited by 1,145
Release of endogenous Zn2+ from brain tissue during activity
Assaf, S. Y., & Chung, S.-H. (1984) · Nature · doi:10.1038/308734a0 · Cited by 1,118
Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase
Hussain, I., Powell, D., Howlett, D. R., Tew, D. G., Meek, T. D., Chapman, C., Gloger, I. S., Murphy, K. E., Southan, C. D., Ryan, D. M., et al. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0811 · Cited by 1,080 · cited 1×
“Additional proteolytic processing of APP by β-secretase (BACE) at the β-cleavage site [5,31,94,171,189] occurs in endosomes [107, 115], where acidic pH necessary for β-secretase activity is possible [198].”
Neurobiology of Zinc and Zinc-Containing Neurons
Frederickson, C. J. (1989) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60279-2 · Cited by 1,075 · cited 3×
“…metalloprotein, or protein-metal complex pool involved in metabolic reactions and non-metabolic functions such as biomembrane structure and support; 2) a vesicular pool localized in nerve terminal synaptic vesicles; and 3) an ionic pool of free or loosely bound ions in the cytoplasm [39].”
The Role of Zinc in Selective Neuronal Death After Transient Global Cerebral Ischemia
Koh, J.-Y., Suh, S. W., Gwag, B. J., He, Y. Y., Hsu, C. Y., & Choi, D. W. (1996) · Science · doi:10.1126/science.272.5264.1013 · Cited by 1,071
Demuro, A., Mina, E., Kayed, R., Milton, S. C., Parker, I., & Glabe, C. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500997200 · Cited by 1,041 · cited 1×
“Increasing evidence suggests that it is these soluble oligomeric species that are the predominant neurotoxic species for neurons [7,199], leading to inhibition of long term potentiation in synaptic hippocampal slices [200,201] and calcium dysregulation and membrane dysfunction [199,202].”
Natural history of mild cognitive impairment in older persons
Bennett, D. A., Wilson, R. S., Schneider, J. A., Evans, D. A., Beckett, L. A., Aggarwal, N. T., Barnes, L. L., Fox, J. H., & Bach, J. (2002) · Neurology · doi:10.1212/wnl.59.2.198 · Cited by 1,037 · cited 2×
“Current data suggest that conversion from MCI to dementia occurs at a rate of 10 to 15% per year [156] with ~80% conversion by the sixth year of followup; although ~5% of MCI subjects remain stable or convert back to normal [13,52].”
Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988
Kayed, R., Sokolov, Y., Edmonds, B., McIntire, T. M., Milton, S. C., Hall, J. E., & Glabe, C. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400260200 · Cited by 902 · cited 1×
“Increasing evidence suggests that it is these soluble oligomeric species that are the predominant neurotoxic species for neurons [7,199], leading to inhibition of long term potentiation in synaptic hippocampal slices [200,201] and calcium dysregulation and membrane dysfunction [199,202].”
Zinc transporters and the cellular trafficking of zinc
Eide, D. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.03.005 · Cited by 874 · cited 1×
“To date, 8 ZnT proteins have been described (reviewed [64]).”
Importance of Zinc in the Central Nervous System: The Zinc-Containing Neuron
Frederickson, C. J., Suh, S. W., Silva, D., Frederickson, C. J., & Thompson, R. B. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.5.1471s · Cited by 866 · cited 1×
“Several subsequent studies have confirmed those findings in AD [148–151] and in amyloid plaques in Tg2576 transgenic mice expressing mutant A β PP [89,152].”
Evidence that production and release of amyloid beta-protein involves the endocytic pathway
Koo, E. H., & Squazzo, S. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32449-3 · Cited by 829
In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity
Pike, C. J., Walencewicz, A. J., Glabe, C. G., & Cotman, C. W. (1991) · Brain Research · doi:10.1016/0006-8993(91)91553-d · Cited by 828
An 18-Year Follow-up of Overweight and Risk of Alzheimer Disease
Gustafson, D., Rothenberg, E., Blennow, K., Steen, B., & Skoog, I. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.13.1524 · Cited by 811 · cited 1×
“], hyperlipidemia [23], hypertension [24], heart disease [25], smoking [26,27], elevated plasma homo-cysteine [28], and obesity [29].”
Stimulation-induced uptake and release of zinc in hippocampal slices
Howell, G. A., Welch, M. G., & Frederickson, C. J. (1984) · Nature · doi:10.1038/308736a0 · Cited by 803 · cited 1×
“Peak extracellular concentrations may reach 300 μM during seizure activity or during neurotransmission [7,89].”
Blennow, K., Wallin, A., Ågren, H., Spenger, C., Siegfried, J., & Vanmechelen, E. (1995) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815140 · Cited by 789 · cited 2×
“Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer’s disease brain: mechanisms and consequences.”
Oddo, S., Billings, L., Kesslak, J. P., Cribbs, D. H., & LaFerla, F. M. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.003 · Cited by 780
Lannfelt, L., Blennow, K., Zetterberg, H., Batsman, S., Ames, D., Harrison, J., Masters, C. L., Targum, S., Bush, A. I., Murdoch, R., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70167-4 · Cited by 725
The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease
Westerman, M. A., Cooper-Blacketer, D., Mariash, A., Kotilinek, L., Kawarabayashi, T., Younkin, L. H., Carlson, G. A., Younkin, S. G., & Ashe, K. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01858.2002 · Cited by 718
Risk of Dementia among Persons with Diabetes Mellitus: A Population-based Cohort Study
Leibson, C. L., Rocca, W. A., Hanson, V. A., Cha, R., Kokmen, E., O'Brien, P. C., & Palumbo, P. J. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009106 · Cited by 700
Snowdon, D. A. (1996) · JAMA · doi:10.1001/jama.1996.03530310034029 · Cited by 696 · cited 1×
“Additional risk factors for AD include head injury [17], low educational attainment and low linguistic ability early in life [18,19], diabetes [ ?”
The elusive function of metallothioneins
Palmiter, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8428 · Cited by 679
Adlard, P. A., Cherny, R. A., Finkelstein, D. I., Gautier, E., Robb, E., Cortes, M., Volitakis, I., Liu, X., Smith, J. P., Perez, K., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.018 · Cited by 672
Screening for dementia with the Memory Impairment Screen
Buschke, H., Kuslansky, G., Katz, M., Stewart, W. F., Sliwinski, M. J., Eckholdt, H. M., & Lipton, R. B. (1999) · Neurology · doi:10.1212/wnl.52.2.231 · Cited by 653
IRIZARRY, M. C., MCNAMARA, M., FEDORCHAK, K., HSIAO, K., & HYMAN, B. T. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199709000-00002 · Cited by 649 · cited 1×
“In addition, studies of transgenic mice, including those with A β PP mutations, show cognitive dysfunction and synaptic damage that precede amyloid plaque deposition and neuron loss [192–196], leading to the suggestion that soluble oligomeric or protofibril A β species may be the most toxic.”
A critical physiological role of zinc in the structure and function of biomembranes
Bettger, W. J., & O'Dell, B. L. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90374-x · Cited by 634 · cited 1×
“Zn is an essential trace element [35] that is redox-inert with structural,catalytic, and regulatory roles [36– 38].”
Evans, D. A., Funkenstein, H. H., Albert, M., Scherr, P. A., Cook, N. R., Chown, M. J., Hebert, L. E., Hennekens, C. H., & Taylor, J. O. (1989) · PubMed · Cited by 599
Mortimer, J. A., Van Duijn, C. M., Chandra, V, Fratiglioni, L., Graves, A. B., Heyman, A., Jorm, A. F., Kokmen, E., Kondo, K., Rocca, W. A., et al. (1991) · International Journal of Epidemiology · doi:10.1093/ije/20.supplement_2.s28 · Cited by 594
Prasad, A. S., Miale, A., FARID, Z., Sandstead, H. H., & Schulert, A. R. (1963) · PubMed · Cited by 586
Transcriptional regulation of the mouse metallothionein-I gene by heavy metals.
Durnam, D. M., & Palmiter, R. D. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69264-1 · Cited by 585 · cited 1×
“In brain, MTs are expressed as three functional isoforms including MT-I and II, which are expressed in astro-M cytes, the perivascular space and pia mater [66] in a Zn-dependent manner [67,68] and MT-III, which is most abundant in neurons that sequester Zn in synaptic vesicles [69].”
Miller, L. M., Wang, Q., Telivala, T. P., Smith, R. J., Lanzirotti, A., & Miklossy, J. (2006) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.09.004 · Cited by 585
Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment
DeCarli, C. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00262-x · Cited by 573 · cited 1×
“Current data suggest that conversion from MCI to dementia occurs at a rate of 10 to 15% per year [3] with ∼ 80% conversion by the sixth year of follow-up, although ∼ 5% of MCI subjects remain stable or convert back to normal [4,5].”
Common mechanisms of amyloid oligomer pathogenesis in degenerative disease
Glabe, C. G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.04.017 · Cited by 569 · cited 1×
“Recent studies suggest that, in addition to insoluble Aβ present in SP, soluble Aβ oligomers are present in the AD brain and may represent the main toxic form of Aβ, thus implicating them in the disease process [79,109,192].”
Dong, J., Atwood, C. S., Anderson, V. E., Siedlak, S. L., Smith, M. A., Perry, G., & Carey, P. R. (2003) · Biochemistry · doi:10.1021/bi0272151 · Cited by 562 · cited 1×
“[56] showed Zn2+ and Cu2+ are specifically coordinated with histidine residues and that chelation of Cu2+ led to a disruption of the β-structure of isolated plaques.”
Aβ toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targets
Klein, W. L. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00050-5 · Cited by 545
Deibel, M. A., Ehmann, W. D., & Markesbery, W. R. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00203-1 · Cited by 540 · cited 1×
“Although initial studies of AD and control brain showed significantly decreased Zn in the hippocampus, inferior parietal lobule and occipital cortex of LAD subjects [3,4,45,55] later studies using short postmortem interval (PMI) tissue specimens from well characterized LAD and control subjects showed significant eleva…”
Evidence of increased oxidative damage in subjects with mild cognitive impairment
Keller, J. N., Schmitt, F. A., Scheff, S. W., Ding, Q., Chen, Q., Butterfield, D. A., & Markesbery, W. R. (2005) · Neurology · doi:10.1212/01.wnl.0000156156.13641.ba · Cited by 539
Wang, H.-W., Pasternak, J. F., Kuo, H., Ristic, H., Lambert, M. P., Chromy, B., Viola, K. L., Klein, W. L., Stine, W. B., Krafft, G. A., et al. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03058-x · Cited by 527
Self-Assembly of Aβ 1 - 42 into Globular Neurotoxins
Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., et al. (2003) · Biochemistry · doi:10.1021/bi030029q · Cited by 522
Evidence for Genetic Linkage of Alzheimer's Disease to Chromosome 10q
Bertram, L., Blacker, D., Mullin, K., Keeney, D., Jones, J., Basu, S., Yhu, S., McInnis, M. G., Go, R. C. P., Vekrellis, K., et al. (2000) · Science · doi:10.1126/science.290.5500.2302 · Cited by 519 · cited 1×
“…[9,10], single nucleotide polymorphisms in the gene that codes for ubiquilin-1 [11], a genetic locus on chromosome 10 that includes the insulin-degrading enzyme [12–14] that may interact with and degrade A β , inherited variants in SORL1 [15], and the presence of apolipoprotein E4 alleles [16].”
γ-Secretase, notch, Aβ and alzheimer's disease: Where do the presenilins fit in?
Sisodia, S. S., & St George-Hyslop, P. H. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn785 · Cited by 512
Aqueous Dissolution of Alzheimer's Disease Aβ Amyloid Deposits by Biometal Depletion
Cherny, R. A., Legg, J. T., McLean, C. A., Fairlie, D. P., Huang, X., Atwood, C. S., Beyreuther, K., Tanzi, R. E., Masters, C. L., & Bush, A. I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23223 · Cited by 482 · cited 2×
“However, in vivo , insoluble A β deposits do not accurately predict the severity of dementia in AD subjects [148].”
Mantyh, P. W., Ghilardi, J. R., Rogers, S., DeMaster, E., Allen, C. J., Stimson, E. R., & Maggio, J. E. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03639.x · Cited by 465 · cited 1×
“In addition to its effect on A β PP processing, several reports indicate that Zn at low physiological concentrations [69,178–180] induces A β aggregation, although later studies indicate that higher Zn concentrations are required [181,182] for significant aggregation (fibril formation).”
ZnT-2, a mammalian protein that confers resistance to zinc by facilitating vesicular sequestration.
Palmiter, R. D., Cole, T. B., & Findley, S. D. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00527.x · Cited by 446 · cited 5×
“Additionally, co-expression of ZnT-1 suppressed ZnT-2 mediated transport into acidic vesicles suggesting ZnT-2 has a relatively low affinity for Zn and functions only under excessive elevations of Zn as a second line of defense when other ZnTs fail to function properly [87].”
InfluentialMovement of zinc and its functional significance in the brain
Takeda, A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00044-8 · Cited by 417 · cited 1×
“Overall, mean brain Zn concentrations are ∼ 10 times serum Zn levels [53] and range between 150 and 200 µ M [54,55].”
Elevated 4-Hydroxynonenal in Ventricular Fluid in Alzheimer’s Disease
Lovell, M. A., Ehmann, W. D., Mattson, M. P., & Markesbery, W. R. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00108-5 · Cited by 412
Self-citationOverview of mammalian zinc transporters
Kambe, T., Yamaguchi-Iwai, Y., Sasaki, R., & Nagao, M. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3148-y · Cited by 407 · cited 1×
“Although ZnT-5 mRNA is found in most organs in mice, the highest protein expression is in pancreas where is it associated with Zn-enriched secretory granules in insulin containing β cells and is scarcely detected in brain [93].”
Protein‐Bound Acrolein: A Novel Marker of Oxidative Stress in Alzheimer's Disease
Calingasan, N. Y., Uchida, K., & Gibson, G. E. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720751.x · Cited by 400
Williams, T. I., Lynn, B. C., Markesbery, W. R., & Lovell, M. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.06.004 · Cited by 392
Self-citationHaug, F.-M. ?. (1967) · Histochemie · doi:10.1007/bf00401978 · Cited by 389 · cited 1×
“Of these sources, the vesicular pool, which is easily chelated, is thought to be the most important [50, 69,86,155] because it is released during neurotransmission and may reach concentrations of 300 μM in the synapse.”
Susceptibility Locus for Alzheimer's Disease on Chromosome 10
Myers, A., Holmans, P., Marshall, H., Kwon, J., Meyer, D., Ramic, D., Shears, S., Booth, J., DeVrieze, F. W., Crook, R., et al. (2000) · Science · doi:10.1126/science.290.5500.2304 · Cited by 386 · cited 1×
“…[9,10], single nucleotide polymorphisms in the gene that codes for ubiquilin-1 [11], a genetic locus on chromosome 10 that includes the insulin-degrading enzyme [12–14] that may interact with and degrade A β , inherited variants in SORL1 [15], and the presence of apolipoprotein E4 alleles [16].”
Ertekin-Taner, N., Graff-Radford, N., Younkin, L. H., Eckman, C., Baker, M., Adamson, J., Ronald, J., Blangero, J., Hutton, M., & Younkin, S. G. (2000) · Science · doi:10.1126/science.290.5500.2303 · Cited by 373 · cited 1×
“Risk factors identified for AD include age [67], genetic factors including presenilin 1 (PS1) and 2 (PS2) and APP mutations [125] [180], single nucleotide polymorphisms in the gene that codes for ubiquilin-1 [16], a genetic locus on chromosome 10 that includes the insulindegrading enzyme [15,65,145] that may interact…”
A novel gene involved in zinc transport is deficient in the lethal milk mouse
Huang, L., & Gitschier, J. (1997) · Nature Genetics · doi:10.1038/ng1197-292 · Cited by 351 · cited 1×
“ZnT-4 exhibits considerable homology with ZnT-2 and 3 and is present in mammary gland and brain [90].”
Cytoarchitectonic distribution of zinc in the hippocampus of man and the rat
Frederickson, C. J., Klitenick, M. A., Manton, W. I., & Kirkpatrick, J. B. (1983) · Brain Research · doi:10.1016/0006-8993(83)90858-2 · Cited by 346 · cited 2×
“One possible mechanism is through the potentiation of glutamate [49,50, 107–110], AMPA [98,111–113]or kainic acid [98,114, 115] toxicity.”
Zabel, U., Schreck, R., & Baeuerle, P. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52428-5 · Cited by 344
(1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00056-1 · Cited by 330
Cellular zinc sensors: MTF-1 regulation of gene expression
Andrews, G. K. (2001) · Biometals · doi:10.1023/a:1012932712483 · Cited by 325 · cited 3×
“Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer’s disease brain: mechanisms and consequences.”
Regulation of the zinc transporter ZnT-1 by dietary zinc
McMahon, R. J., & Cousins, R. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.4841 · Cited by 316 · cited 1×
“], hyperlipidemia [23], hypertension [24], heart disease [25], smoking [26,27], elevated plasma homo-cysteine [28], and obesity [29].”
Tønder, N., Johansen, F. F., Frederickson, C. J., Zimmer, J., & Diemer, N. H. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90002-q · Cited by 301
The function of metallothionein
Vallee, B. L. (1995) · Neurochemistry International · doi:10.1016/0197-0186(94)00165-q · Cited by 300 · cited 1×
“MTs are ubiquitous and can be induced by metals, glucocorticoids, pro-inflammatory cytokines, oxidative stress, electrophilic compounds, and xenobiotics [63–65].”
Gosavi, N., Lee, H.-J., Lee, J. S., Patel, S., & Lee, S.-J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208194200 · Cited by 294 · cited 1×
“A potential role for ZnT-3 and synaptic Zn in SP formation in transgenic mice was suggested by recent studies that showed crossing mice expressing mutant APP with ZnT-3 null mice led to diminished Aβ deposition [81].”
Bush, A. I., Multhaup, G., Moir, R. D., Williamson, T. G., Small, D. H., Rumble, B., Pollwein, P., Beyreuther, K., & Masters, C. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85394-2 · Cited by 286
Kinoshita, A., Fukumoto, H., Shah, T., Whelan, C. M., Irizarry, M. C., & Hyman, B. T. (2003) · Journal of Cell Science · doi:10.1242/jcs.00643 · Cited by 284 · cited 1×
“Additional proteolytic processing of A β PP by β -secretase (BACE) at the β -cleavage site [167–171] occurs in endosomes [172,173], where acidic pH necessary for β - secretase activity is possible [166].”
Brain, aging and neurodegeneration: Role of zinc ion availability
Mocchegiani, E., Bertoni-Freddari, C., Marcellini, F., & Malavolta, M. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.005 · Cited by 283 · cited 1×
“…inhibition of gamma aminobutyric acid (GABA-ergic) neurotrans-mission [44], modulation of protein kinase C (PKC) signaling pathways [45], modulation of p53-mediated DNA repair through stabilization of p53/genomicDNA interactions [46], and modulation of glycogen synthase kinase-3 β [47,48].”
Hunter, F. E., & Ford, L. (1955) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52312-2 · Cited by 279 · cited 1×
“step of respiration – the transfer of an electron between coenzyme Q and cytochrome b of the bc1 complex [19,93,111].”
ZnT7, a Novel Mammalian Zinc Transporter, Accumulates Zinc in the Golgi Apparatus
Kirschke, C. P., & Huang, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207644200 · Cited by 271 · cited 1×
“Similar to ZnT-6, ZnT-7 functions to sequester Zn in the TGN but has expression limited to lung and small intestine [96].”
Zeng, J., Heuchel, R., Schaffner, W., & Kägi, J. H. R. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80175-3 · Cited by 254
Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain.
Cornett, C., Markesbery, W. R., & Ehmann, W. D. (1998) · PubMed · Cited by 251
Lipid Peroxidation and Free Radical Scavengers in Alzheimer’s Disease
Jeandel, C., Nicolas, M. B., Dubois, F., Nabet-Belleville, F., Penin, F., & Cuny, G. (1989) · Gerontology · doi:10.1159/000213037 · Cited by 250 · cited 1×
“…et al. [154], Molina et al. [155], and Shore et al. [114] showed no significant differences between AD and control serum Zn, whereas Jeandel et al. [156] showed a significant decrease in Zn and other nutrients and antioxidant properties in AD serum, although the AD group may have contained…”
Zinc neurotoxicity in cortical cell culture
Choi, D. W., Yokoyama, M., & Koh, J. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90312-0 · Cited by 244 · cited 2×
“One possible mechanism is through the potentiation of glutamate [49,50, 107–110], AMPA [98,111–113]or kainic acid [98,114, 115] toxicity.”
Oxidative Stress Activates Metal-responsive Transcription Factor-1 Binding Activity
Dalton, T. P., Li, Q., Bittel, D., Liang, L., & Andrews, G. K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.26233 · Cited by 236 · cited 1×
“…and transcription factors where it serves as an essential cofactor for catalytic activity [39] or by conferring structural stability to Zn finger domains of DNA binding proteins [40] including stimulating protein-1 (sp-1), a transcription factor responsible for ∼ 30% of A β PP transcription [41–43].”
Excitation-Transcription Coupling Mediated by Zinc Influx through Voltage-dependent Calcium Channels
Atar, D., Backx, P. H., Appel, M. M., Gao, W. D., & Marban, E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2473 · Cited by 229 · cited 3×
“Zinc influx into cells by NMDA receptor channels may lead to a depolarization of the cells resulting in a rise of calcium (Ca) that could activate second messenger systems via PKC-mediated phosphorylation of receptor ion channels or voltage-dependent gene expression [8,144,164].”
Family-Based Association between Alzheimer's Disease and Variants in UBQLN1
Bertram, L., Hiltunen, M., Parkinson, M., Ingelsson, M., Lange, C., Ramasamy, K., Mullin, K., Menon, R., Sampson, A. J., Hsiao, M. Y., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042765 · Cited by 229 · cited 1×
“…(PS1) and 2 (PS2) and amyloid-β protein precursor (A β PP) mutations [9,10], single nucleotide polymorphisms in the gene that codes for ubiquilin-1 [11], a genetic locus on chromosome 10 that includes the insulin-degrading enzyme [12–14] that may interact with and degrade A β , inherited variants…”
Amyloid-beta precursor protein processing in neurodegeneration
Wilquet, V., & Strooper, B. D. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.08.001 · Cited by 229 · cited 2×
“Additional proteolytic processing of A β PP by β -secretase (BACE) at the β -cleavage site [167–171] occurs in endosomes [172,173], where acidic pH necessary for β - secretase activity is possible [166].”
Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease.
Basun, H., Forssell, L. G., Wetterberg, L., & Winblad, B. G. (1991) · PubMed · Cited by 228
Zinc toxicity on cultured cortical neurons: Involvement of N-methyl-d-aspartate receptors
Koh, J.-Y., & Choi, D. W. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90282-8 · Cited by 222
Functional Characterization of a Novel Mammalian Zinc Transporter, ZnT6
Huang, L., Kirschke, C. P., & Gitschier, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200462200 · Cited by 212 · cited 1×
“ZnT-6 functions to sequester cytoplasmic Zn in the trans-Golgi network (TGN) and vesicular compartments [94], and in mice, ZnT-6 mRNA is present in multiple organs including brain.”
Metal Concentrations in Plasma and Cerebrospinal Fluid in Patients with Alzheimer’s Disease
Gerhardsson, L., Lundh, T., Minthon, L., & Londos, E. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000129365 · Cited by 210 · cited 1×
“In addition, recent studies [78,183] show there is an inverse relationship between Zn and copper concentrations and levels of Aβ1-42 in CSF of LAD subjects and that degradation of soluble Aβ is normally promoted by physiologic concentrations of both Cu and Zn [183].”
Huang, L., Kirschke, C. P., Zhang, Y., & Yu, Y. Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412188200 · Cited by 208 · cited 1×
“ZIP proteins are predicted to have eight transmembrane domains with a histidine-rich intracellular loop between domains 3 and 4 [72] and are part of the plasma membrane or membranes of intracellular organelles.”
Moechars, D., Lorent, K., De Strooper, B., Dewachter, I., & Van Leuven, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00468.x · Cited by 201
The influence of smoking on the risk of Alzheimer’s disease
Merchant, C., Tang, M.-X., Albert, S., Manly, J., Stern, Y., & Mayeux, R. (1999) · Neurology · doi:10.1212/wnl.52.7.1408 · Cited by 197
Brain trace elements in Alzheimer's disease.
Ehmann, W. D., Markesbery, W. R., Alauddin, M., Hossain, T. I., & Brubaker, E. H. (1986) · PubMed · Cited by 192
Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains
Wenstrup, D., Ehman, W. D., & Markesbery, W. R. (1990) · Brain Research · doi:10.1016/0006-8993(90)91804-p · Cited by 189 · cited 1×
“…inferior parietal lobule and occipital cortex of LAD subjects [138–141]later studies using short postmortem interval (PMI) tissue specimens from well characterized LAD and control subjects showed significant elevations of Zn in LAD hippocampus, amygdala, and multiple neocortical areas [58,142–146].”
Bittel, D., Dalton, T., Samson, S. L.-A., Gedamu, L., & Andrews, G. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.7127 · Cited by 188 · cited 1×
“…and transcription factors where it serves as an essential cofactor for catalytic activity [39] or by conferring structural stability to Zn finger domains of DNA binding proteins [40] including stimulating protein-1 (sp-1), a transcription factor responsible for ∼ 30% of A β PP transcription [41–43].”
Brief exposure to zinc is toxic to cortical neurons
Yokoyama, M., Koh, J., & Choi, D. W. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90646-4 · Cited by 182 · cited 1×
“Although Zn is essential for normal brain function, experimental studies show high concentrations of Zn are toxic to neurons in vitro [98–100] and in vivo [101– 103] with increased oxidative stress, and necrotic and apoptotic cell death occurring in as little as 30 min [98, 104–106].”
Zn2+ transporters and Zn2+ homeostasis in neurons
Colvin, R. A., Fontaine, C. P., Laskowski, M., & Thomas, D. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.067 · Cited by 180 · cited 4×
“In addition to ZIP proteins, neuronal Zn uptake may also be mediated by Zn-permeable membrane spanning channels including voltage gated L-type Ca2+ [42], N-methyl-D aspartate (NMDA) receptor gated [113], Ca2+ permeable AMPA/kainate channels [98] and Na+/Zn2+ exchangers [34].”
InfluentialZalewski, P. D., Forbes, I. J., Seamark, R. F., Borlinghaus, R., Betts, W. H., Lincoln, S. F., & Ward, A. D. (1994) · Chemistry & Biology · doi:10.1016/1074-5521(94)90005-1 · Cited by 177
Korichneva, I., Hoyos, B., Chua, R., Levi, E., & Hammerling, U. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205634200 · Cited by 177 · cited 1×
“…including inhibition of gamma aminobutyric acid (GABA-ergic) neurotrans-mission [44], modulation of protein kinase C (PKC) signaling pathways [45], modulation of p53-mediated DNA repair through stabilization of p53/genomicDNA interactions [46], and modulation of glycogen synthase kinase-3 β…”
Zn2+ entry produces oxidative neuronal necrosis in cortical cell cultures
Kim, E. Y., Koh, J. Y., Kim, Y. H., Sohn, S., Joe, E., & Gwag, B. J. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00437.x · Cited by 175
Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains
Danscher, G., Jensen, K. B., Frederickson, C. J., Kemp, K., Andreasen, A., Juhl, S., Stoltenberg, M., & Ravid, R. (1997) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(97)00079-4 · Cited by 174 · cited 2×
“Although initial studies of AD and control brain showed significantly decreased Zn in the hippocampus, inferior parietal lobule and occipital cortex of LAD subjects [3,4,45,55] later studies using short postmortem interval (PMI) tissue specimens from well characterized LAD and control subjects showed significant eleva…”
Danscher, G., Howell, G., P�rez-Clausell, J., & Hertel, N. (1985) · Histochemistry · doi:10.1007/bf00509203 · Cited by 170
Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease
Molina, J. A., Jiménez-Jiménez, F. J., Aguilar, M. V., Meseguer, I., Mateos-Vega, C. J., González-Muñoz, M. J., de Bustos, F., Porta, J., Ortí-Pareja, M., Zurdo, M., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050071 · Cited by 167
Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid
Altschul, D., Launer, L. J., Adlard, P. A., Cherny, R. A., Tsatsanis, A., Volitakis, I., Blennow, K., Petrovitch, H., White, L. R., & Bush, A. I. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.012 · Cited by 165
Ilouz, R., Kaidanovich, O., Gurwitz, D., & Eldar-Finkelman, H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00636-8 · Cited by 160 · cited 1×
“In addition to its structural and catalytic roles, recent studies suggest free Zn has important signaling functions including inhibition of gamma aminobutyric acid (GABA-ergic) neurotransmission [84], modulation of protein kinase C (PKC) signaling pathways [116], modulation of p53 mediated DNA repair through stabiliza…”
Expression and regulation of brain metallothionein
Ebadi, M., Iversen, P. L., Hao, R., CERUTIS, D. R., Rojas, P., Happe, H. K., Murrin, L. C., & Pfeiffer, R. F. (1995) · Neurochemistry International · doi:10.1016/0197-0186(94)00164-p · Cited by 157 · cited 1×
“Overall, mean brain Zn concentrations are ~ 10 times serum Zn levels [184] and range between 150 and 200 μM [62,160].”
Inhibition of the DNA‐binding activity of NF‐κB by gold compounds in vitro
Yang, J.-P., Merin, J. P., Nakano, T., Kato, T., Kitade, Y., & Okamoto, T. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00157-5 · Cited by 154
Modulating Amyloid Self-Assembly and Fibril Morphology with Zn(II)
Dong, J., Shokes, J. E., Scott, R. A., & Lynn, D. G. (2006) · Journal of the American Chemical Society · doi:10.1021/ja055973j · Cited by 149 · cited 1×
“More recent studies using atomic force and transmission electron microscopy and Aβ13-21 show Zn2+ specifically controls the rate of fibril assembly and regulates fibril morphology via specific coordination sites [57].”
Butterfield, D. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033456422 · Cited by 149 · cited 2×
“Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer’s disease brain: mechanisms and consequences.”
SNOWDON, D. A., GREINER, L. H., & MARKESBERY, W. R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06347.x · Cited by 148 · cited 1×
“Additional risk factors for AD include head injury [17], low educational attainment and low linguistic ability early in life [18,19], diabetes [ ?”
Measurement of Intracellular Free Zinc Concentrations Accompanying Zinc-Induced Neuronal Death
Canzoniero, L. M. T., Turetsky, D. M., & Choi, D. W. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-19-j0005.1999 · Cited by 147 · cited 2×
“More recent studies [121– 123] show that nM – µ M concentrations of Zn inhibit a number of enzymes required for mitochondrial respiration and glycolysis and that exposure to 100 µ M Zn caused a 50% loss of intracellular phosphate [123].”
Mucke, L., Yu, G.-Q., McConlogue, L., Rockenstein, E. M., Abraham, C. R., & Masliah, E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64839-0 · Cited by 145
Friedlich, A. L., Lee, J.-Y., van Groen, T., Cherny, R. A., Volitakis, I., Cole, T. B., Palmiter, R. D., Koh, J.-Y., & Bush, A. I. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0297-04.2004 · Cited by 139 · cited 2×
“More recently, Friedlich and collaborators [89] showed that these mice also demonstrate reduced cerebral amyloid angiopathy that is hypothesized to be due to diminished Zn concentrations in the perivascular space of ZnT-3 null mice.”
Characterization of Zinc-Induced Neuronal Death in Primary Cultures of Rat Cerebellar Granule Cells
Manev, H., Kharlamov, E. A., Uz, T., Mason, R. P., & Cagnoli, C. M. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6510 · Cited by 138
Enrichment of glutamate in zinc-containing terminals of the cat visual cortex
Beaulieu, C., Dyck, R., & Cynader, M. (1992) · NeuroReport · doi:10.1097/00001756-199210000-00010 · Cited by 137 · cited 1×
“One possible mechanism is through the potentiation of glutamate [49,50, 107–110], AMPA [98,111–113]or kainic acid [98,114, 115] toxicity.”
Dalton, T. P., Bittel, D., & Andrews, G. K. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2781 · Cited by 137 · cited 1×
“Zinc is an essential trace element [159] that is redox inert with structural, catalytic, and regulatory roles [17,80,186] and functions as a crucial component in over 300 enzymes and transcription factors where it serves as an essential cofactor for catalytic activity [70] or by conferring structural stability to Zn f…”
Lee, J.-Y., Mook-Jung, I., & Koh, J.-Y. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-j0002.1999 · Cited by 136 · cited 1×
“Several subsequent studies have confirmed those findings in AD [148–151] and in amyloid plaques in Tg2576 transgenic mice expressing mutant A β PP [89,152].”
Chan, S. L., Griffin, W. S. T., & Mattson, M. P. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990801)57:3<315::aid-jnr3>3.0.co;2-# · Cited by 136
Inhibition of the respiratory chain by zinc ions
Skulachev, V. P., Chistyakov, V. V., JASAITIS, A. A., & Smirnova, E. G. (1967) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(67)90242-2 · Cited by 135 · cited 1×
“At high concentrations, Zn inhibits levels of complex I and II and cytochrome oxidase [119], although Yamaguchi et al. [120] demonstrated increased mitochondrial function in rat liver after a single low dose of Zn.”
Zinc‐Induced Aggregation of Human and Rat β‐Amyloid Peptides In Vitro
Esler, W. P., Stimson, E. R., Jennings, J. M., Ghilardi, J. R., Mantyh, P. W., & Maggio, J. E. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66020723.x · Cited by 135
A POSSIBLE ROLE OF ZINC IN THE PATHOLOGY OF DEMENTIA
Burnet, F. M. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90062-3 · Cited by 131 · cited 2×
“Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer’s disease brain: mechanisms and consequences.”
Hippocampal tin, aluminum and zinc in Alzheimer's disease
Corrigan, F. M., Reynolds, G. P., & Ward, N. (1993) · BioMetals · doi:10.1007/bf00205853 · Cited by 129 · cited 1×
“Although initial studies of AD and control brain showed significantly decreased Zn in the hippocampus, inferior parietal lobule and occipital cortex of LAD subjects [3,4,45,55] later studies using short postmortem interval (PMI) tissue specimens from well characterized LAD and control subjects showed significant eleva…”
Zinc ion-induced assembly of tubulin.
Gaskin, F., & Kress, Y. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39936-2 · Cited by 126 · cited 2×
“Zinc is hypothesized to induce structural abnormalities by influencing assembly and disassembly of tubulin [61,76,77] and several microtubule associated proteins in vitro [9,76, 77,117].”
Elemental imbalances in the olfactory pathway in Alzheimer's disease
Samudralwar, D. L., Diprete, C. C., Ni, B. F., Ehmann, W. D., & Markesbery, W. R. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00018-w · Cited by 124
González, Martín, Cacho, Breñas, Arroyo, García‐Berrocal, Navajo, & González‐Buitrago (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00471.x · Cited by 121 · cited 3×
“Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer’s disease brain: mechanisms and consequences.”
Molecular Basis for Differential Inhibition of Glutamate Transporter Subtypes by Zinc Ions
Vandenberg, R. J., Mitrovic, A. D., & Johnston, G. A. R. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.189 · Cited by 121 · cited 1×
“At relatively low concentrations, Zn inhibits sodium/potassium ATPase (Na + K + ATPase) activity in isolated protein, inhibits glutamate and GABA uptake in mice synaptosomes [125] and glutamate transport by human excitatory amino acid transporter (EAAT) 1 in Xenopus laevis oocytes [126].”
Jia, Y., Jeng, J., Sensi, S. L., & Weiss, J. H. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.020172 · Cited by 118 · cited 1×
“In addition to ZIP proteins, neuronal Zn uptake may also be mediated by Zn-permeable membrane spanning channels including voltage gated L-type Ca2+ [42], N-methyl-D aspartate (NMDA) receptor gated [113], Ca2+ permeable AMPA/kainate channels [98] and Na+/Zn2+ exchangers [34].”
Clements, A., Allsop, D., Walsh, D. M., & Williams, C. H. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66020740.x · Cited by 116 · cited 2×
“In addition to its effect on APP processing, several reports indicate that Zn at low physiological concentrations [25–27,134] induces Aβ aggregation, although later studies indicate that higher Zn concentrations are required [41,66] for significant aggregation (fibril formation).”
Alzheimer's disease and the amyloid cascade hypothesis: ten years on
Sommer, B. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00126-6 · Cited by 109 · cited 1×
“…etiologic/pathogenic mechanisms have been suggested for the cause of AD including genetic defects [10,30], the amyloid cascade hypothesis (reviewed in [31]), trace element toxicity (reviewed in [32]), the oxidative stress hypothesis [33], mitochondrial defects [34], or a combination of the above.”
Backstrom, J. R., Miller, C. A., & Tökés, Z. A. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09352.x · Cited by 109 · cited 5×
“Additionally, high Zn concentrations can inhibit matrix metalloproteinase-2 (MMP-2) [9], which is able to partially degrade soluble Aβ1-42 in vitro [14].”
InfluentialBramham, C. R., Torp, R., Zhang, N., Storm‐Mathisen, J., & Ottersen, O. P. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90277-b · Cited by 109 · cited 2×
“Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer’s disease brain: mechanisms and consequences.”
Zn2+ permeates Ca2+permeable AMPA/kainate channels and triggers selective neural injury
Yin, H. Z., & Weiss, J. H. (1995) · NeuroReport · doi:10.1097/00001756-199512150-00025 · Cited by 108
Kumar-Singh, S., Dewachter, I., Moechars, D., Lübke, U., De Jonghe, C., Ceuterick, C., Checler, F., Naidu, A., Cordell, B., Cras, P., et al. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0272 · Cited by 107
Nolte, C., Gore, A., Sekler, I., Kresse, W., Hershfinkel, M., Hoffmann, A., Kettenmann, H., & Moran, A. (2004) · Glia · doi:10.1002/glia.20065 · Cited by 107 · cited 1×
“More recent studies demonstrated that ZnT-1 reduces Zn influx through the L-type calcium channels without increasing Zn efflux [84–86].”
An, W., Bjorkdahl, C., Liu, R., Cowburn, R. F., Winblad, B., & Pei, J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02948.x · Cited by 106 · cited 2×
“In addition, Zn has been shown to mediate tau phosphorylation through modulation of P13/AKT, ERK1/2 and p38/MAPK signaling cascades [47].”
Pérez‐Clausell, J., & Danscher, G. (1986) · Brain Research · doi:10.1016/0006-8993(86)90463-4 · Cited by 105
Palmiter, R. D. (1995) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1995.1216 · Cited by 103
Smith, J. L., Xiong, S., Markesbery, W. R., & Lovell, M. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.049 · Cited by 103 · cited 1×
“In the only studies of ZnT-6 in human brain, we show significantly increased ZnT-6 levels in the HPG of EAD and LAD subjects compared to normal controls and a trend toward a significant elevation in MCI [95].”
Self-citationRegulation of protein kinase C activity by cooperative interaction of Zn2+ and Ca2+.
Murakami, K., Whiteley, M. K., & Routtenberg, A. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47879-9 · Cited by 101 · cited 1×
“Zn influx into cells by NM-DA receptor channels may lead to a depolarization of the cells resulting in a rise of calcium (Ca) that could activate second messenger systems via PKC-mediated phosphorylation of receptor ion channels or voltage-dependent gene expression [67,131,132].”
Intracellular zinc distribution and transport in C6 rat glioma cells
Haase, H., & Beyersmann, D. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02017-x · Cited by 101 · cited 1×
“In addition to its structural and catalytic roles, recent studies suggest free Zn has important signaling functions including inhibition of gamma aminobutyric acid (GABA-ergic) neurotransmission [84], modulation of protein kinase C (PKC) signaling pathways [116], modulation of p53 mediated DNA repair through stabiliza…”
Zinc ion binding to human brain calcium binding proteins. Calmodulin and S100b protein
Baudier, J., Haglid, K. G., Haiech, J., & Gérard, D. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)90681-2 · Cited by 99 · cited 1×
“Zn may also disrupt Ca homeostasis by binding to calmodulin [133] and through the inhibition of calmodulin-complexedCa ATPase [134].”
Stengaard‐Pedersen, K., Fredens, K., & Larsson, L. (1983) · Brain Research · doi:10.1016/0006-8993(83)91097-1 · Cited by 93
Zinc inhibition of calmodulin: A proposed molecular mechanism of zinc action on cellular functions
Brewer, G. J., Aster, J. C., Knutsen, C. A., & Kruckeberg, W. C. (1979) · American Journal of Hematology · doi:10.1002/ajh.2830070107 · Cited by 88 · cited 1×
“Zn may also disrupt Ca homeostasis by binding to calmodulin [133] and through the inhibition of calmodulin-complexedCa ATPase [134].”
Oxidant-induced mobilization of zinc from metallothionein
Fliss, H., & Ménard, M. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90384-9 · Cited by 86 · cited 1×
“A dysfunction in oxidative phosphorylation, coupled with the presence of free radicals, could in turn lead to release of Zn from MT and increased intracellular concentrations of Zn [124].”
Chowanadisai, W., Kelleher, S. L., & Lönnerdal, B. L. (2005) · Journal of Nutrition · doi:10.1093/jn/135.5.1002 · Cited by 86 · cited 3×
“Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer’s disease brain: mechanisms and consequences.”
Cheng, C., & Reynolds, I. J. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062401.x · Cited by 80 · cited 2×
“In addition to ZIP proteins, neuronal Zn uptake may also be mediated by Zn-permeable membrane spanning channels including voltage gated L-type Ca2+ [42], N-methyl-D aspartate (NMDA) receptor gated [113], Ca2+ permeable AMPA/kainate channels [98] and Na+/Zn2+ exchangers [34].”
Serum Zinc Levels and Alzheimer's Disease
Rulon, L. L., Robertson, J. D., Lovell, M. A., Deibel, M. A., Ehmann, W. D., & Markesbery, W. R. (2000) · Biological Trace Element Research · doi:10.1385/bter:75:1-3:79 · Cited by 79 · cited 1×
“In contrast, Rulon et al. [157] and Gonzales et al. [158] showed significant elevations of Zn in AD serum.”
Self-citationKelleher, S. L., & Lönnerdal, B. L. (2002) · Journal of Nutrition · doi:10.1093/jn/132.11.3280 · Cited by 78 · cited 1×
“ZnT-4 functions to sequester Zn in acidic vesicles and is best characterized in its involvement in the transport of Zn 2+ into milk during lactation [91].”
A role for ZnT-1 in regulating cellular cation influx
Segal, D., Ohana, E., Besser, L., Hershfinkel, M., Moran, A., & Sekler, I. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.211 · Cited by 77
Silencing of ZnT-1 expression enhances heavy metal influx and toxicity
Ohana, E., Sekler, I., Kaisman‐Elbaz, T., Kahn, N., Cove, J., Silverman, W. F., Amsterdam, A., & Hershfinkel, M. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0062-4 · Cited by 76
Duncan, M., Marini, A., Watters, R., Kopin, I., & Markey, S. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-04-01523.1992 · Cited by 72 · cited 1×
“Although Zn is essential for normal brain function, experimental studies show high concentrations of Zn are toxic to neurons in vitro [37,59,203] and in vivo [40,47,114] with increased oxidative stress, and necrotic and apoptotic cell death occurring in as little as 30 min [37,76,133] [106].”
Krotkiewska, B., & Banaś, T. (1992) · International Journal of Biochemistry · doi:10.1016/0020-711x(92)90078-f · Cited by 68
Response of olfactory Schwann cells to intranasal zinc sulfate irrigation
Chuah, M. I., Tennent, R., & Jacobs, I. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490420405 · Cited by 68 · cited 1×
“Although Zn is essential for normal brain function, experimental studies show high concentrations of Zn are toxic to neurons in vitro [98–100] and in vivo [101– 103] with increased oxidative stress, and necrotic and apoptotic cell death occurring in as little as 30 min [98, 104–106].”
Tubulin-zinc interactions: binding and polymerizaton studies
Eagle, G. R., Zombola, R. R., & Himes, R. H. (1983) · Biochemistry · doi:10.1021/bi00270a032 · Cited by 67
Ferritin: a zinc detoxicant and a zinc ion donor.
Price, D., & Joshi, J. G. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.10.3116 · Cited by 67 · cited 1×
“Overall, mean brain Zn concentrations are ∼ 10 times serum Zn levels [53] and range between 150 and 200 µ M [54,55].”
Serum Zinc in the Progression of Alzheimer's Disease
Dong, J., Robertson, J. D., Markesbery, W. R., & Lovell, M. A. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15310 · Cited by 65 · cited 1×
“In more recent studies of serum Zn in the progression of AD, we observed a statistically significant decrease of serum Zn in men with MCI comparedto women with MCI or age-matched normal control men [159].”
Self-citationLiu, X., Lovell, M. A., & Lynn, B. C. (2006) · Chemical Research in Toxicology · doi:10.1021/tx0502903 · Cited by 60
Self-citationImmersion autometallographic tracing of zinc ions in Alzheimer beta-amyloid plaques
Stoltenberg, M., Bruhn, M., Søndergaard, C. S., Doering, P., West, M. J., Larsen, A., Troncoso, J. C., & Danscher, G. (2005) · Histochemistry and Cell Biology · doi:10.1007/s00418-005-0787-0 · Cited by 60
Freund, W.-D., & Reddig, S. (1994) · Brain Research · doi:10.1016/0006-8993(94)90487-1 · Cited by 54
Hair and Serum Copper, Zinc, Calcium, and Magnesium Concentrations in Alzheimer‐type Dementia
Shore, D., Henkin, R. I., Nelson, N. R., Agarwal, R. P., & Wyatt, R. J. (1984) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1984.tb00889.x · Cited by 52
Elevated Zinc Transporter-6 in Mild Cognitive Impairment, Alzheimer Disease, and Pick Disease
Lovell, M. A., Smith, J. L., & Markesbery, W. R. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000229237.98124.91 · Cited by 51 · cited 1×
“Studies from our laboratory show ZnT-1 protein expression andfunc-tion can be inactivated by hydroxynonenal [80], a neurotoxic aldehydic marker of lipid peroxidation present in MCI and LAD brain [81,82].”
Self-citationBergeron, C., Petrunka, C. N., & Weyer, L. (1996) · PubMed Central · Cited by 50
Cuajungco, M. P., & Lees, G. J. (1996) · Neuroreport · doi:10.1097/00001756-199605170-00017 · Cited by 48 · cited 1×
“Although Zn is essential for normal brain function, experimental studies show high concentrations of Zn are toxic to neurons in vitro [37,59,203] and in vivo [40,47,114] with increased oxidative stress, and necrotic and apoptotic cell death occurring in as little as 30 min [37,76,133] [106].”
Brain Iron and Zinc Contents of German Patients with Alzheimer Disease
Andrási, E., Farkas, É., Gawlik, D., Rösick, U., & Brätter, P. (2000) · Journal of Alzheimer's Disease · doi:10.3233/jad-2000-2103 · Cited by 47 · cited 2×
“Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer’s disease brain: mechanisms and consequences.”
On the inhibition of mitochondrial electron transport by Zn2+ ions
Kleiner, D., & von JAGOW, G. (1972) · FEBS Letters · doi:10.1016/0014-5793(72)80802-0 · Cited by 45
Penkowa, M., Nielsen, H. S., Hidalgo, J., Bernth, N., & Moos, T. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990920)412:2<303::aid-cne9>3.0.co;2-g · Cited by 43
Abnormal tubulin aggregates induced by zinc sulfate in organotypic cultures of nerve tissue
Gaskin, F., Kress, Y., Brosnan, C. F., & Bornstein, M. B. (1978) · Neuroscience · doi:10.1016/0306-4522(78)90130-6 · Cited by 42 · cited 1×
“Zn is hypothesized to induce structural abnormalities by influencing assembly and disassembly of tubulin [104,127,128] and several microtubule associated proteins in vitro [104,128–130].”
Quantification of hippocampal noradrenaline and zinc changes after selective cell destruction
Kesslak, J. P., Frederickson, C. J., & Gage, F. H. (1987) · Experimental Brain Research · doi:10.1007/bf00269455 · Cited by 40
Effects of divalent metal ions on the uptake of glutamate and GABA from synaptosomal fractions
Gabrielsson, B., Robson, T., Norris, D. K., & Chung, S. (1986) · Brain Research · doi:10.1016/0006-8993(86)91157-1 · Cited by 40 · cited 1×
“At relatively low concentrations, Zn inhibits sodium/potassium ATPase (Na + K + ATPase) activity in isolated protein, inhibits glutamate and GABA uptake in mice synaptosomes [125] and glutamate transport by human excitatory amino acid transporter (EAAT) 1 in Xenopus laevis oocytes [126].”
Effects of zinc on the cytoskeletal proteins in the central nervous system of the rat
Kress, Y., Gaskin, F., Brosnan, C. F., & Levine, S. (1981) · Brain Research · doi:10.1016/0006-8993(81)90217-1 · Cited by 40
Concentration of elements in human brain: glioblastoma multiforme
Andrási, E., Suhajda, M., Sáray, I., Bezúr, L., Ernyei, L., & Réffy, A. (1993) · The Science of The Total Environment · doi:10.1016/0048-9697(93)90036-6 · Cited by 35 · cited 2×
“Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer’s disease brain: mechanisms and consequences.”
Rubin, H., & Koide, T. (1973) · Journal of Cellular Physiology · doi:10.1002/jcp.1040810311 · Cited by 35 · cited 1×
“Zn influx into cells by NM-DA receptor channels may lead to a depolarization of the cells resulting in a rise of calcium (Ca) that could activate second messenger systems via PKC-mediated phosphorylation of receptor ion channels or voltage-dependent gene expression [67,131,132].”
Ho, L. H., Ratnaike, R. N., & Zalewski, P. D. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2090 · Cited by 34 · cited 1×
“More recent studies [32,88, 118] show that nM – μM concentrations of Zn inhibit a number of enzymes required for mitochondrial respiration and glycolysis and that exposure to 100 μM Zn caused a 50% loss of intracellular phosphate [88].”
Determination of main and trace element contents in human brain by NAA and ICP-AES methods
Andrási, E., Nádasdi, J., Molnar, Z., Bezúr, L., & Ernyei, L. (1990) · Biological Trace Element Research · doi:10.1007/bf02992725 · Cited by 31 · cited 1×
“…studies of AD and control brain showed significantly decreased Zn in the hippocampus, inferior parietal lobule and occipital cortex of LAD subjects [138–141]later studies using short postmortem interval (PMI) tissue specimens from well characterized LAD and control subjects showed significant…”
Role of zinc as an activator of mitochondrial function in rat liver
Yamaguchi, M., KURA, M., & Okada, S. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90018-1 · Cited by 31
Zinc Status Influences Zinc Transport by Porcine Brain Capillary Endothelial Cells
Lehmann, H. M., Brothwell, B. B., Volak, L. P., & Bobilya, D. J. (2002) · Journal of Nutrition · doi:10.1093/jn/132.9.2763 · Cited by 29
Ectopic Expression of Musashi-1 in Alzheimer Disease and Pick Disease
Lovell, M. A., & Markesbery, W. R. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000173891.17176.5b · Cited by 26 · cited 1×
“Additionally, in the only study of ZnT-1 in AD, our Western blot analyses show significantly decreased ZnT-1 in the hippocampus/parahippocampal gyrus (HPG) of MCI, but significant elevations in EAD and LAD [83].”
Self-citationHaines, A., Iliffe, S., Morgan, P. G. M., Dormandy, T. L., & Wood, B. (1991) · Clinica Chimica Acta · doi:10.1016/0009-8981(91)90360-o · Cited by 23 · cited 2×
“Haines et al. [154], Molina et al. [155], and Shore et al. [114] showed no significant differences between AD and control serum Zn, whereas Jeandel et al. [156] showed a significant decrease in Zn and other nutrients and antioxidant properties in AD serum, although the AD group may have contained…”
The contribution of a zinc finger motif to the function of yeast ribosomal protein YL37a
Rivlin, A., Chan, Y., & Wool, I. G. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3309 · Cited by 19
Rapid changes in intracellular Zn2+ in rat hepatocytes
Kleineke, J. W., & Brand, I. A. (1997) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(97)00094-4 · Cited by 16
Research works printed but not linked: 5
- [80]Golden BE Mills CF Zinc in cell division and tissue growth: Physiological aspects Zinc in Human Biology Springer-Verlag London 1989 119 127
- [135]Markesbery WR Ehmann WD Terry RD Katzman R Trace element alterations in Alzheimer’s disease Alzheimer’s disease Raven Press New York 1994
- [156]Petersen RC Morris JC Petersen RC Clinical features Mild Cognitive Impairment Oxford University New York 2003 15 39
- [180]St George-Hyslop PH Terry RD Katzman R Bick LL The molecular genetics of Alzheimer’s disease Alzheimer’s disease Raven Press New York 1994 345 352
- [196]Williams RJP Mills CF An introduction to the biochemistry of zinc Zinc in Human Biology Springer-Verlag London 1989 15 31
Cited by
Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease
Prasad, A. S. (2013) · Advances in Nutrition · doi:10.3945/an.112.003210 · Cited by 919
“Lovell (93) reported that AB/Zn ratios 1:0.”
Zinc in the physiology and pathology of the CNS
Sensi, S. L., Paoletti, P., Bush, A. I., & Sekler, I. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2734 · Cited by 759
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672
Copper, zinc and iron in neurodegenerative diseases (Alzheimer's, Parkinson's and prion diseases)
Kozlowski, H., Luczkowski, M., Remelli, M., & Valensin, D. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.013 · Cited by 437
Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta‐analysis
Lopes da Silva, S., Vellas, B., Elemans, S., Luchsinger, J., Kamphuis, P., Yaffe, K., Sijben, J., Groenendijk, M., & Stijnen, T. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.05.1771 · Cited by 311
“Zinc and calcium share many transport and signaling pathways [80] and have been implicated in the disease process [81].”
Metadata
- Authors
- Lovell, M. A.
- Affiliations
- University of Kentucky (US)
- Corresponding author
- Lovell, Mark A.
- ORCID
- Lovell, Mark A.
- Venue
- Journal of Alzheimer s Disease
- Publisher
- SAGE Publications
- Published
- 2009-03-09
- Volume
- 16
- Issue
- 3
- Pages
- 471-483
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC2881701
- OpenAlex
- W2138475095
- Cited by
- 87
- References
- 199
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 5 · 2022: 7 · 2021: 4 · 2020: 9 · 2019: 2 · 2018: 3 · 2017: 5 · 2016: 4 · 2015: 4 · 2014: 2 · 2013: 11 · 2012: 10
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (P30AG028383, P01AG005119, R01AG016269)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- zinc
- MeSH terms
- Aged, Alzheimer Disease, Carrier Proteins, Cognition Disorders, Humans, Zinc, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.